Cart (0 Items)
Your cart is currently empty.
View ProductsAntibody production
-
Antibody productionWhat makes antibody therapeutics uniquely fitted to fight autoimmune disorders?
Philippe Funfrock
Autoimmune disorders afflict almost 10% of the global population, with a particular incidence in young and middle-aged women. Despite the increasing diversity of autoimmune conditions, these diseases are typically characterized…
-
How advanced monoclonal antibody generation methods are improving conventional envenoming treatments
Snakebite envenoming has been on WHO’s priority list of neglected tropical diseases since 2017. Due to the complexity and variability… Read More
-
“Cell-based phage display is helping us isolate more biologically relevant antibodies”
Dr. Mohamed Alfaleh is an assistant professor at King Abdulaziz University (Faculty of Pharmacy, Jeddah, Saudi Arabia). Pharmacist by training,… Read More
-
Can a single amino acid mutation change the course of the COVID-19 pandemic?
Viruses mutate in the course of an epidemic as a result of selective pressure or genetic drift. Resulting mutations may… Read More
-
Essential antibody library generation and display technologies for the discovery of new reagents and biopharmaceuticals
Library generation is a vital first step in any antibody phage display project for therapeutic applications and others. Libraries… Read More
-
Can successful anticancer immunotherapies change the course of the COVID-19 disease?
A recent study revealed the hidden parallelisms in our organism’s response to cancer and COVID-19. Despite the marked differences between… Read More
-
Why phage display for monoclonal antibody production remains an unrivaled technology
Phage display technology revolutionized antibody discovery. By coupling the structural simplicity of phages with the fast replication and high turnover… Read More
-
How to leverage recombinant monoclonal antibody production to increase clinical success rates
Ever since the onset of recombinant technology, therapeutic biologics production has gradually shifted from native to recombinant expression. Today, recombinant… Read More
-
Will a single COVID-19 drug be enough to treat all patients?
As more and more biotherapeutics enter the early stages of clinical development, scientists are questioning if current approaches will be… Read More
-
Will camelid antibodies offer a solution to solve the COVID-19 pandemic?
The emergence of the zoonotic pathogen, SARS-CoV-2, resulted in a global pandemic and caused the deaths of hundreds of thousands… Read More